Expect the New Pneumonia Antibiotic, Xenleta, to Be Saved for Rare Occasions

October 2019

Xenleta (zen-LEH-tah, lefamulin) will be a new antibiotic for community-acquired pneumonia (CAP).

It'll be touted to cover resistant infections...since it works differently than other antibiotics (azithromycin, etc).

Plus it will be promoted to reduce hospital stays...since patients can start with the IV form and finish with oral tabs.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Controlled Substances Help Protect Your Workplace Against Drug Diversion
Insulin Be Prepared if Your Pharmacy Stocks the New Insulin Premix, Myxredlin
Practice Use Strategies to Promote Teamwork in Your Pharmacy
Fungal Infections Follow Contact Precautions for Patients With Candida auris
Pain Management Look for Buprenorphine Dose Changes for Some Surgery Patients
Antibiotics Expect the New Pneumonia Antibiotic, Xenleta, to Be Saved for Rare Occasions
Influenza Get Ready to Dispense 2019-2020 Influenza Vaccines
Contraceptives Slynd, a New Oral Contraceptive, May Pop Up on Home Med Lists
IBS Watch for Zelnorm to Return for Irritable Bowel Syndrome
E-Cigarettes Don't Be Surprised to See Inpatients With Lung Injury From E-Cigs